- Home
- SCPH vs LIEN Comparison
SCPH vs LIEN Comparison
Compare SCPH & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- LIEN
- Stock Information
- Founded
- SCPH 2013
- LIEN 2021
- Country
- SCPH United States
- LIEN United States
- Employees
- SCPH N/A
- LIEN N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- LIEN
- Sector
- SCPH Health Care
- LIEN
- Exchange
- SCPH Nasdaq
- LIEN NYSE
- Market Cap
- SCPH 274.7M
- LIEN 292.1M
- IPO Year
- SCPH 2017
- LIEN 2022
- Fundamental
- Price
- SCPH $3.26
- LIEN $12.35
- Analyst Decision
- SCPH Strong Buy
- LIEN
- Analyst Count
- SCPH 2
- LIEN 0
- Target Price
- SCPH $15.00
- LIEN N/A
- AVG Volume (30 Days)
- SCPH 544.0K
- LIEN 6.7K
- Earning Date
- SCPH 11-13-2024
- LIEN 11-07-2024
- Dividend Yield
- SCPH N/A
- LIEN 8.83%
- EPS Growth
- SCPH N/A
- LIEN N/A
- EPS
- SCPH N/A
- LIEN 0.67
- Revenue
- SCPH $30,278,000.00
- LIEN $12,681,914.00
- Revenue This Year
- SCPH $174.12
- LIEN N/A
- Revenue Next Year
- SCPH $133.41
- LIEN N/A
- P/E Ratio
- SCPH N/A
- LIEN $18.52
- Revenue Growth
- SCPH 303.87
- LIEN 22.94
- 52 Week Low
- SCPH $3.08
- LIEN $7.29
- 52 Week High
- SCPH $6.71
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- SCPH 43.13
- LIEN N/A
- Support Level
- SCPH $3.11
- LIEN N/A
- Resistance Level
- SCPH $3.67
- LIEN N/A
- Average True Range (ATR)
- SCPH 0.21
- LIEN 0.00
- MACD
- SCPH 0.01
- LIEN 0.00
- Stochastic Oscillator
- SCPH 31.54
- LIEN 0.00
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.